Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients With Esophageal or Gastric Cancer
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to clarify whether octreotide therapy can reduce undesired
postoperative weight loss, increase health-related quality of life and improve the appetite
after surgery for esophageal or gastric cancer.